Next Biomedical
Nano-based drug delivery for interventional medicine
Incheon, South Korea · Founded 2014
- Headquarters
- Incheon
- Founded
- 2014
- Business Model
- B2B
- Website
- nextbiomedical.co.kr
About
Next Biomedical (NEXTBIOMEDICAL) is a South Korean medical device company founded in 2014 and listed on KOSDAQ (389650). Headquartered in Incheon, South Korea, the company specializes in nano-based drug delivery systems and therapeutic materials for interventional medical procedures. Its core technology platform enables minimally invasive treatment across gastrointestinal, vascular, and orthopedic applications. Notable products include Nexpowder, a hemostatic powder agent designed for gastrointestinal bleeding. The company combines biomedical materials science with drug delivery innovation to develop next-generation medical devices for clinical use in interventional medicine.
Summary
Next Biomedical is a Biotech company based in Incheon, South Korea, founded in 2014.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.